Biotech Values

[rfj1862]

>This however may not be such a problem for smart small bio stocks that have a financial cushion and/or seek partnerships from the big pharma stocks that are getting decimated and looking for additional business. That also could drive a takeover spree by big pharma that could give some of these a boost.<

I'd agree with that. Many small biotechs who might otherwise stubbornly hold tight to their products are likely to partner or be bought out in such a situation. Although premiums are likely to be lower in this situation, there will still be money to be made. Combine with dry pipelines and changes in accounting rules and it's bye bye baby biotech.